TD Asset Management Inc. reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.4% during the second quarter, Holdings Channel reports. The firm owned 597,757 shares of the medical instruments supplier’s stock after selling 8,265 shares during the period. TD Asset Management Inc.’s holdings in DENTSPLY SIRONA were worth $38,758,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. boosted its position in DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares during the period. Principal Financial Group Inc. boosted its position in DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock valued at $330,488,000 after buying an additional 4,950,337 shares during the period. Clearbridge Investments LLC boosted its position in DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock valued at $328,313,000 after buying an additional 1,353,040 shares during the period. Point72 Asset Management L.P. bought a new position in DENTSPLY SIRONA during the first quarter valued at $64,184,000. Finally, Renaissance Technologies LLC boosted its position in DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock valued at $65,222,000 after buying an additional 742,700 shares during the period. Institutional investors own 95.17% of the company’s stock.
Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 56.23 on Thursday. DENTSPLY SIRONA Inc. has a 52 week low of $55.00 and a 52 week high of $65.68. The stock has a market cap of $12.89 billion, a price-to-earnings ratio of 36.18 and a beta of 1.26. The firm has a 50-day moving average price of $63.39 and a 200 day moving average price of $62.35.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.65. DENTSPLY SIRONA had a return on equity of 7.37% and a net margin of 9.42%. The business had revenue of $992.70 million for the quarter, compared to the consensus estimate of $1 billion. During the same quarter in the previous year, the company posted $0.76 EPS. The company’s revenue was down 2.9% compared to the same quarter last year. On average, analysts forecast that DENTSPLY SIRONA Inc. will post $2.84 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is 22.58%.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/2798028/dentsply-sirona-inc-xray-shares-sold-by-td-asset-management-inc.html.
Several research analysts recently weighed in on XRAY shares. Goldman Sachs Group, Inc. (The) cut shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and decreased their price objective for the stock from $60.00 to $55.00 in a research report on Tuesday, May 23rd. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Wednesday, April 19th. Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. HC Wainwright started coverage on shares of DENTSPLY SIRONA in a research report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price objective on the stock. Finally, BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. DENTSPLY SIRONA has a consensus rating of “Buy” and an average price target of $67.92.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.